Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 616-621.e3 , March 2010

Blood transfusion is associated with increased morbidity and mortality after lower extremity revascularization

Presented at the 2009 Vascular Annual Meeting, Denver, Colo, June 11-14, 2009.

  • Shane D. O'Keeffe, MD

      Affiliations

    • University of Kentucky Medical Center, Lexington, Ky
    • ,
  • Daniel L. Davenport, PhD

      Affiliations

    • University of Kentucky Medical Center, Lexington, Ky
    • ,
  • David J. Minion, MD

      Affiliations

    • University of Kentucky Medical Center, Lexington, Ky
    • ,
  • Ehab E. Sorial, MD

      Affiliations

    • University of Kentucky Medical Center, Lexington, Ky
    • ,
  • Eric D. Endean, MD

      Affiliations

    • University of Kentucky Medical Center, Lexington, Ky
    • ,
  • Eleftherios Sarantis Xenos, MD, PhD

      Affiliations

    • University of Kentucky Medical Center, Lexington, Ky
    • VA Medical Center, Lexington, Ky
    • Corresponding Author InformationReprint requests: Eleftherios S. Xenos, MD, PhD, University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536

Received 2 July 2009 ,Accepted 3 October 2009.

References 

  1. Murphy GJ, Reeves BC, Rogers CA, Rivzi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–2552
  2. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–1562
  3. Jani SM, Smith DE, Share D, Kline-Rogers E, Khanal S, O'Donnell MJ, et al. Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention. Clin Cardiol. 2007;30(10 Suppl 2):II49–II56
  4. Leal-Noval SR, Rincon-Ferrari MD, Garcıa-Curiel A, Herruzo-Aviles A, Camacho-Larana P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119:1461–1468
  5. Chelemer SB, Prato BS, Cox PM, Morton JR. Association of bacterial infection and red blood cell transfusion after coronary artery bypasses surgery. Ann Thorac Surg. 2002;73:138–142
  6. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham CJ. Effect of blood transfusion on long term survival after cardiac operation. Ann Thorac Surg. 2002;74:1180–1186
  7. Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care (National VA Surgical Quality Improvement Program). Ann Surg. 1998;228:491–507
  8. Khuri SF, Henderson WG, Daley J, Jonasson O, Jones RS, Campbell DA, et al. The patient safety in surgery study: background, study design, and patient populations. J Am Coll Surg. 2007;204:1089–1102
  9. Daley J, Khuri SF, Henderson W, Hur K, Gibbs JO, Barbour G, et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg. 1997;185:328–340
  10. Haller M, Forst H. Red cell transfusion in the critical care setting. Transfusion Sci. 1997;18:459
  11. Busch MP. Closing the windows on viral transmission by blood transfusion. In:  Stramer SL editors. Blood safety in the new millennium. Bethesda (MD): American Association of Blood Banks; 2001;p. 33–54
  12. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. [see comment] Transfusion. 2002;42:975–979
  13. King KE, Shirey RS, Thoman SK, Bensen-Kennedy D, Tanz WS, Ness PM. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004;44:25–29
  14. Tinmouth A, Fergusson D, Yee IC ABLE Investigators; Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46:2014–2027
  15. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papasideri IS. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion. 2007;47:1212–1220
  16. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: when is it not safe?. Crit Care Med. 2003;31(12 Suppl):S687–S697
  17. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–1239
  18. Vincent JL, Baron JF, Reinhart K, Gattitoni L, Thijs L, Webb A, et al. ABC (Anemia and Blood Transfusion in Critical Care) Investigators Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499–1507
  19. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: Anemia and blood transfusion in the critically ill–current clinical practice in the United States. Crit Care Med. 2004;32:39–52
  20. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005;33:1191–1198
  21. Shorr AF, Jackson WL, Kelly KM, Fu M, Kollef MH. Transfusion practice and blood stream infections in critically ill patients. Chest. 2005;127:1722–1728
  22. Taylor RW, O'Brien J, Trottier SJ, Manganaro L, Cytron M, Lesko MF, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med. 2006;34:2302–2308
  23. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18:184–188
  24. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33:721–726
  25. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005;19:2–31
  26. Kopko PM. Leukocyte antibodies and biologically active mediators in the pathogenesis of transfusion-related acute lung injury. Curr Hematol Rep. 2004;3:456–461
  27. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engoren M, Durham SJ, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med. 2005;33:1749–1756
  28. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230–1236
  29. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care (Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group). N Engl J Med. 1999;340:409–417
  30. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 2002;68:566–572
  31. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003;54:898–905
  32. Raghavan M, Marik PE. Anemia, allogeneic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127:295–307
  33. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327–348
  34. Fergusson D, Khanna MP, Tinmouth A, Hebert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth. 2004;51:417–424
  35. Corwin HL, AuBuchon JP. Is leukoreduction of blood components for everyone?. JAMA. 2003;289:1993–1995

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)02095-3

doi: 10.1016/j.jvs.2009.10.045

Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 616-621.e3 , March 2010

Article Tools

* Image Usage & Resolution